19 Patents
- US122757752025Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122757762025Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122214682025Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121802562024Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121509792024Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121215722024Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120972482024Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US120763802024Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120704912024Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120362712024Peptides and Combination of Peptides as Targets or Active Ingredients for Use in Immunotherapy Against AML and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US118979352024Peptides, Combination of Peptides as Targets and for Use in Immunotherapy Against Gallbladder Cancer and Cholangiocarcinoma and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118979362024Peptides, Combination of Peptides as Targets and for Use in Immunotherapy
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117865832023Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117796382023Method of Eliciting a CD8+ Cytotoxic Response in Hepatocellular Carcinoma Patients with a Population of Activated T Cells
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116791472023Method of Eliciting a CD8+ Cytotoxic Response in Hepatocellular Carcinoma Patients with a Population of Activated T Cells
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116728482023Method of Eliciting a CD8+ Cytotoxic Response in Hepatocellular Carcinoma Patients with a Population of Activated T Cells
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115977522023Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115769562023Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115595732023Method of Eliciting a CD8+ Cytotoxic Response in Hepatocellular Carcinoma Patients with a Population of Activated T Cells
IMMATICS BIOTECHNOLOGIES GmbH
0 cites